Non adherence to inhalational medications and associated factors among patients with asthma in a referral hospital in Ethiopia, using validated tool TAI

Asthma Research and Practice 2017 3:7
 

https://doi.org/10.1186/s40733-017-0035-0

Abstract

Background

Asthma is a chronic inflammatory condition of the airways that affects roughly 358 million people globally. It is a serious global health problem with an increasing prevalence worldwide. Most people affected are in low- and middle-income countries including Ethiopia. The association between non -adherence and poor disease control is clearly stated in different literatures. The main objective of the present study was to assess self-reported non- adherence level and to identify the potential factors associated with non-adherence.

Methods

An institution based cross-sectional study was conducted in university of Gondar teaching and referral hospital. The data was collected using a validated tool called Test of Adherence to Inhalers (TAI).

Result

Among the total of study participants, higher proportions of patients were female (57.3%). Large number of the respondents (59.1%) were Unable to read and write. 18.3% of inhalational user asthmatic patients were not adherent to inhalational medications. According to this study only 49.4% of the respondents were adherent to inhalations and 32.3% of them were intermediate adherent to inhalational anti asthmatics medications. Lack of education about the Proper use of inhalational anti-asthmatics medications, poly pharmacy and co-morbidities were statistically significant factors associated with non-adherence.

Conclusion

The rate of non-adherence to inhalational anti asthmatics is high. Therefore, promoting optimal medication adherences through education, proper patient consultation is essential to optimize the benefits of treatment. Measurement of the degree of non-adherence to inhaled treatment in each individual patient is important in early interventional practice.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @EAACI_HQ: Assessing severity of #anaphylaxis: pros and cons of the multiple #anaphylaxis severity-scoring instruments used in literatur…
9hreplyretweetfavorite
Interasma RT @IPCRG: Implementation pack nearly ready. We hope to have it running too! Fantastic experiences to share from Canada, Spain, Portugal…
9hreplyretweetfavorite
Interasma RT @KulikovUNIATF: India’s toxic air claimed 1.24 million lives in 2017, or 12.5% of total deaths recorded that year. #airpolluton #BeatNCD
9hreplyretweetfavorite
Interasma RT @Aller_MD: Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature https://t.co/4j8S7Ee4p5
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma